WebCarsten Niemann, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark, presents results from the prospective, randomized Phase II HOVON-141/VISION tr... Web14 de mar. de 2024 · Chronic lymphocytic leukemia (CLL) is the most common leukemia in Western countries. The clinical course of CLL is highly heterogeneous. During the last decade, the treatment options for CLL has developed from single and combination chemotherapy to immune-chemotherapy and targeted agents, thereby significantly …
GCLLSG HO500 CLL - Trials
Web7 de abr. de 2024 · The phase II HOVON 139/GiVe trial is the first available study to investigate the efficacy and safety of a predetermined 12-cycle venetoclax consolidation compared to MRD-guided venetoclax consolidation following a fixed-duration combination therapy of venetoclax plus obinutuzumab. Web22 de mar. de 2024 · Venetoclax–Rituximab Treatment in CLL In a trial involving patients with relapsed or refractory chronic lymphocytic leukemia, ... (A.P.K., on behalf of the HOVON CLL working group). ... tmjava
HOVON Trial: Hematopoietic Cell Transplant Superior to Novel …
WebProtocol description of the HOVON 141/ VISION trial: a prospective, multicentre, randomised phase II trial of ibrutinib plus venetoclax in patients with creatinine clearance ≥30 mL/min who have relapsed or refractory chronic lymphocytic leukaemia (RR-CLL) with or without TP53 aberrations Web11 de nov. de 2024 · About HOVON HOVON central office ; HOVON Data Center ... CLL: 09JUN2024. CLL guideline (Dutch only) CML: 14APR2024: CML guideline (Dutch only) HCLc: 09NOV2024: HCLc guideline (Dutch only) HCLv: 27SEP2024: HCLv guideline (Dutch only) LGL: 04SEP2024: LGL guideline (Dutch only) MDS: JAN 2013: Web23 de nov. de 2024 · Volume 138, Issue Supplement 1. November 23 2024. ISSN 0006-4971. EISSN 1528-0020. In this Issue. Plenary Abstracts. Oral Abstracts. tm jayarathna dj nonstop mp3